Clinical Trials Browser

Enrolling by invitation × Carboplatin × Gastrointestinal × Clear all

NCT05385861 2025-08-15

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

Phase 1/2 Enrolling by invitation

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma